Macrogenics (NASDAQ: MGNX) reported Q1 EPS of ($0.65), in-line with the analyst estimate of ($0.65). Revenue for the quarter came in at $13.19 million versus the consensus estimate of $14.06 million.

For earnings history and earnings-related data on Macrogenics (MGNX) click here.